Literature DB >> 2658886

Automated control of postoperative hypertension: a prospective, randomized multicenter study.

D M Cosgrove1, J H Petre, J L Waller, J V Roth, C Shepherd, L H Cohn.   

Abstract

Hypertension after a cardiac operation is a frequent phenomenon. Complications resulting from this include bleeding, disruption of vascular suture lines, subendocardial ischemia, and possible cerebrovascular accidents. Treatment with sodium nitroprusside has become accepted practice to prevent these complications. To improve control of arterial blood pressure, a closed-loop system for sodium nitroprusside administration was developed. A prospective, randomized multicenter study was carried out postoperatively in 180 cardiac surgical patients to evaluate the performance of this system compared with manual control of infusion. Adherence of mean arterial blood pressure to +/- 10% of the target blood pressure occurred 85% of the time with the automatic system and 61% of the time with manual regulation (p less than 0.0001). With the automatic system, there was less hypertension (9% versus 22%; p less than 0.0001) and hypotension (6% versus 22%; p less than 0.0001). The superior control of hypertension was achieved more rapidly with less requirement for nurse regulation of infusion rate. The superior control of blood pressure resulted in less chest tube drainage in the automatic mode (720 mL versus 840 mL; p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2658886     DOI: 10.1016/0003-4975(89)90117-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Closed-loop control of arterial pressure during cardiac surgery.

Authors:  J F Martin
Journal:  J Clin Monit       Date:  1992-07

2.  Closed-loop control for anesthesia breathing systems.

Authors:  D R Westenskow; C F Wallroth
Journal:  J Clin Monit       Date:  1990-07

3.  Fuzzy control in anesthesia.

Authors:  J F Martin
Journal:  J Clin Monit       Date:  1994-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.